Yingqi Zhou

784 total citations
20 papers, 577 citations indexed

About

Yingqi Zhou is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yingqi Zhou has authored 20 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Yingqi Zhou's work include Pancreatic and Hepatic Oncology Research (9 papers), Renal and related cancers (3 papers) and MicroRNA in disease regulation (3 papers). Yingqi Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Renal and related cancers (3 papers) and MicroRNA in disease regulation (3 papers). Yingqi Zhou collaborates with scholars based in China and United States. Yingqi Zhou's co-authors include Chenghao Shao, Xiangui Hu, Shuyu Zhang, Jun Hao, Gang Jin, Cong Liu, Wei Jing, Xuyu Zhou, Yijie Zhang and Rui Liu and has published in prestigious journals such as Nature Medicine, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Yingqi Zhou

18 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingqi Zhou China 12 358 225 204 112 65 20 577
Jennifer Hanson Canada 11 294 0.8× 270 1.2× 206 1.0× 83 0.7× 103 1.6× 20 562
Xiangui Hu China 15 433 1.2× 338 1.5× 234 1.1× 98 0.9× 60 0.9× 27 627
Yanfen Ye China 9 272 0.8× 183 0.8× 151 0.7× 52 0.5× 31 0.5× 9 489
Lifeng Wang China 16 244 0.7× 144 0.6× 177 0.9× 94 0.8× 110 1.7× 34 504
Jue‐Yu Zhou China 15 426 1.2× 278 1.2× 110 0.5× 38 0.3× 54 0.8× 42 591
Sen Guo China 14 361 1.0× 202 0.9× 172 0.8× 166 1.5× 65 1.0× 27 560
David B. Zhen United States 13 276 0.8× 227 1.0× 432 2.1× 156 1.4× 83 1.3× 40 646
Chuanming Zheng China 16 245 0.7× 194 0.9× 194 1.0× 150 1.3× 108 1.7× 56 639
Youyou Xia China 14 227 0.6× 185 0.8× 349 1.7× 106 0.9× 208 3.2× 27 633

Countries citing papers authored by Yingqi Zhou

Since Specialization
Citations

This map shows the geographic impact of Yingqi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqi Zhou more than expected).

Fields of papers citing papers by Yingqi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingqi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqi Zhou. The network helps show where Yingqi Zhou may publish in the future.

Co-authorship network of co-authors of Yingqi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yingqi Zhou. A scholar is included among the top collaborators of Yingqi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqi Zhou. Yingqi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jing, Weiqing, et al.. (2019). [Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy].. PubMed. 57(7). 534–539. 3 indexed citations
3.
Song, Bin, Qi Bian, Gang Li, et al.. (2015). Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy. PLoS ONE. 10(3). e0120694–e0120694. 21 indexed citations
4.
Song, Bin, Qi Bian, Yijie Zhang, et al.. (2015). Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation. Molecular Cancer. 14(1). 177–177. 43 indexed citations
5.
Song, Bin, Qi Bian, Chenghao Shao, et al.. (2015). Sox2 function as a negative regulator to control HAMP expression. Biological Research. 48(1). 23–23.
6.
Shao, Zhuo, Weiping Ji, An‐An Liu, et al.. (2015). TSG101 Silencing Suppresses Hepatocellular Carcinoma Cell Growth by Inducing Cell Cycle Arrest and Autophagic Cell Death. Medical Science Monitor. 21. 3371–3379. 15 indexed citations
7.
Wei, Jing, Ying Chen, Lei Lü, et al.. (2014). Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells Producing IL15 Eradicate Established Pancreatic Tumor in Syngeneic Mice. Molecular Cancer Therapeutics. 13(8). 2127–2137. 61 indexed citations
8.
Liu, Chen, Rachid Karam, Yingqi Zhou, et al.. (2014). The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nature Medicine. 20(6). 596–598. 99 indexed citations
9.
Jin, Gang, Zhuo Shao, Xiangui Hu, et al.. (2013). Efficacy and prognosis analysis of 2061 cases of pancreatic cancer resection. 13(1). 1–4. 4 indexed citations
10.
Zhou, Jianguang, et al.. (2013). Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus. Clinical and Experimental Hypertension. 36(5). 321–325. 8 indexed citations
11.
Peng, Cheng, Gang Jin, Xiangui Hu, et al.. (2012). Analysis of tumor‐induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus. Cancer Science. 103(10). 1756–1763. 17 indexed citations
12.
Zhou, Jianguang, et al.. (2012). Prevalence and distinguishing features of masked hypertension in type 2 diabetic patients. Journal of Diabetes and its Complications. 27(1). 82–86. 11 indexed citations
13.
Li, Gang, et al.. (2012). Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma. Molecular Medicine Reports. 5(4). 1106–1110. 15 indexed citations
14.
Zhou, Yingqi, Gang Li, Yuan Ji, et al.. (2012). Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line. Journal of Biomedical Science. 19(1). 15–15. 11 indexed citations
15.
Jing, Wei, Guanghui Zhu, Xiangui Hu, et al.. (2012). Distal Pancreatectomy with En Bloc Celiac Axis Resection for the Treatment of Locally Advanced Pancreatic Body and Tail Cancer. Hepatogastroenterology. 60(121). 187–90. 14 indexed citations
16.
Jing, Wei, Gang Jin, Xuyu Zhou, et al.. (2011). Diabetes mellitus and increased risk of cholangiocarcinoma. European Journal of Cancer Prevention. 21(1). 24–31. 72 indexed citations
17.
Hao, Jun, Shuyu Zhang, Yingqi Zhou, et al.. (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochemical and Biophysical Research Communications. 406(4). 552–557. 88 indexed citations
18.
Hao, Jun, Shuyu Zhang, Yingqi Zhou, Xiangui Hu, & Chenghao Shao. (2010). MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Letters. 585(1). 207–213. 92 indexed citations
19.
Zhou, Yingqi, et al.. (2007). [Rare variation of abdominal aorta breaking in two].. PubMed. 87(43). 3060–3. 1 indexed citations
20.
Xu, Bin, et al.. (2002). [Endovascular intervention versus traditional bypass for treatment of Budd-Chiari syndrome].. PubMed. 40(6). 423–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026